Stay updated on Durvalumab with Chemoradiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page
- Check6 days agoChange DetectedRecord History now shows Revision: v3.3.3 as the latest revision, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.3.2 added and v3.3.1 removed from the page history header.SummaryDifference0.1%

- Check35 days agoChange DetectedNew revision entry v3.3.1 added to the history and the previous entry v3.2.0 removed.SummaryDifference0.1%

- Check42 days agoChange DetectedRemoved the header banner about government funding/operating status; the study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedVersion 38 was added to the study record history on 2025-10-27. The page also shows the 'Study Status' navigation item, highlighting a new or updated section for viewing status.SummaryDifference0.4%

- Check85 days agoChange DetectedAdded a government operations notice and a version upgrade to v3.2.0; removed the v3.1.0 tag.SummaryDifference10%

Stay in the know with updates to Durvalumab with Chemoradiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab with Chemoradiation in Lung Cancer Clinical Trial page.